Cel Sci Corp Stock Number Of Shares Shorted
| CVM Stock | USD 4.91 0.59 10.73% |
Fundamental analysis of CEL SCI allows traders to better anticipate movements in CEL SCI's stock price by examining its financial health and performance throughout various phases of its business cycle.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. CEL SCI Corp Company Number Of Shares Shorted Analysis
CEL SCI's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current CEL SCI Number Of Shares Shorted | 526.58 K |
Most of CEL SCI's fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CEL SCI Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, CEL SCI Corp has 526.58 K of outstending shares currently sold short by investors. This is 83.54% lower than that of the Biotechnology sector and 89.67% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 88.81% higher than that of the company.
CEL Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CEL SCI's direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CEL SCI could also be used in its relative valuation, which is a method of valuing CEL SCI by comparing valuation metrics of similar companies.CEL SCI is currently under evaluation in number of shares shorted category among its peers.
CEL Fundamentals
| Return On Equity | -3.28 | ||||
| Return On Asset | -0.7 | ||||
| Current Valuation | 53.01 M | ||||
| Shares Outstanding | 7.99 M | ||||
| Shares Owned By Insiders | 8.20 % | ||||
| Shares Owned By Institutions | 10.70 % | ||||
| Number Of Shares Shorted | 526.58 K | ||||
| Price To Earning | (1.14) X | ||||
| Price To Book | 6.38 X | ||||
| Price To Sales | 11,797 X | ||||
| Gross Profit | (16.66 M) | ||||
| EBITDA | (22.21 M) | ||||
| Net Income | (26.92 M) | ||||
| Cash And Equivalents | 4.74 M | ||||
| Cash Per Share | 0.65 X | ||||
| Total Debt | 11.62 M | ||||
| Debt To Equity | 0.41 % | ||||
| Current Ratio | 7.71 X | ||||
| Book Value Per Share | 1.32 X | ||||
| Cash Flow From Operations | (18.81 M) | ||||
| Short Ratio | 5.30 X | ||||
| Earnings Per Share | (9.13) X | ||||
| Target Price | 42.5 | ||||
| Number Of Employees | 10 | ||||
| Beta | 0.51 | ||||
| Market Capitalization | 53.14 M | ||||
| Total Asset | 26.99 M | ||||
| Retained Earnings | (514.01 M) | ||||
| Working Capital | 1.44 M | ||||
| Current Asset | 5.89 M | ||||
| Current Liabilities | 4.01 M | ||||
| Net Asset | 26.99 M |
About CEL SCI Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CEL SCI Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CEL SCI using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CEL SCI Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out CEL SCI Piotroski F Score and CEL SCI Altman Z Score analysis. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CEL SCI. If investors know CEL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CEL SCI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of CEL SCI Corp is measured differently than its book value, which is the value of CEL that is recorded on the company's balance sheet. Investors also form their own opinion of CEL SCI's value that differs from its market value or its book value, called intrinsic value, which is CEL SCI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CEL SCI's market value can be influenced by many factors that don't directly affect CEL SCI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CEL SCI's value and its price as these two are different measures arrived at by different means. Investors typically determine if CEL SCI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CEL SCI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.